control
viral
infect
mainli
caus
influenza
virus
great
interest
public
health
sever
studi
shown
presenc
activ
properti
hemolymph
arthropod
interest
develop
new
pharmacolog
drug
recent
demonstr
exist
potent
antivir
properti
hemolymph
lonomia
obliqua
caterpillar
aim
studi
produc
antivir
protein
cell
system
result
bacmid
contain
sequenc
code
antivir
protein
previous
describ
group
total
rna
l
obliqua
caterpillar
extract
trizol
use
revers
transcript
assay
oligo
primer
follow
polymeras
chain
reaction
rtpcr
specif
primer
cdna
code
antivir
protein
base
sequenc
deposit
genbank
databas
restrict
site
insert
cdna
ligat
donor
plasmid
recombin
plasmid
select
escherichia
coli
subsequ
use
transform
e
coli
construct
recombin
bacmid
bacmid
use
express
antivir
protein
cell
system
identifi
protein
western
blot
activ
test
perform
show
purifi
recombin
protein
abl
significantli
reduc
viral
replic
log
studi
optim
express
system
product
antivir
protein
insect
cell
progress
elsevi
bv
correspond
author
address
de
parasitologia
instituto
butantan
av
vital
brasil
cep
paulo
sp
brazil
tel
fax
first
licens
human
therapeut
protein
use
recombin
dna
technolog
insulin
produc
larg
scale
escherichia
coli
howev
due
imposs
express
complex
protein
posttransl
modif
bacteria
anim
cell
becom
attract
altern
industri
purpos
butler
anim
cell
cultur
develop
last
decad
centuri
first
attempt
hold
piec
fabric
plasma
biolog
fluid
sever
day
week
sinc
technolog
anim
cell
cultur
achiev
great
progress
current
one
success
tool
biotechnolog
kretzmer
anim
cell
cultur
requir
complex
medium
often
supplement
expens
bovin
serum
provid
essenti
protein
growth
factor
remov
downstream
process
reyesruiz
barrerasaldana
attract
altern
use
express
baculovirusinsect
cell
system
describ
smith
et
al
system
wide
use
tool
product
recombin
protein
requir
complex
posttransl
modif
carpenti
et
al
glycosyl
addit
carbohydr
glycan
protein
synthes
anim
cell
one
exampl
posttransl
modif
paramet
cell
cultur
nutrient
oxygen
toxic
metabolit
concentr
ph
temperatur
may
signific
effect
glycan
structur
distribut
recombin
protein
therefor
requir
effici
control
butler
sever
protein
also
target
biotechnolog
industri
due
larg
commerci
interest
context
caterpillar
lonomia
obliqua
gain
great
promin
biotechnolog
brazil
owe
activ
properti
identifi
venom
hemolymph
veiga
et
al
interfer
blood
elsevi
bv
coagul
fibrinolysi
veiga
et
al
enhanc
cell
growth
maranga
et
al
act
antiapoptot
agent
souza
et
al
improv
recombin
protein
product
mendonca
et
al
vieira
et
al
demonstr
antivir
effect
present
studi
describ
system
protein
express
cell
use
recombin
dna
obtain
protein
l
obliqua
caterpillar
display
potent
antivir
action
protein
found
hemolymph
l
obliqua
caterpillar
encod
cdna
sequenc
basic
element
construct
express
system
larg
protein
express
allow
analysi
function
biochem
character
preliminari
descript
cell
system
use
express
antivir
protein
hemolymph
l
obliqua
caterpillar
determin
protein
cdna
sequenc
construct
recombin
protein
sequenc
determin
primer
design
design
primer
specif
amplif
cdna
code
put
antivir
protein
base
protein
cdna
sequenc
identif
protein
sequenc
l
obliqua
hemolymph
purifi
fraction
contain
antivir
properti
analyz
sdspage
ntermin
sequenc
antivir
protein
determin
maldiqtof
mass
spectrometri
wattenberg
et
al
order
identifi
cdna
code
protein
interest
ntermin
sequenc
analyz
cdna
librari
l
obliqua
tegument
spicul
veiga
et
al
use
possibl
translat
frame
cdna
sequenc
respect
cdna
use
primer
design
cdna
amplif
pcr
restrict
site
also
includ
primer
sequenc
ligat
plasmid
invitrogen
well
histag
sequenc
antivir
respons
baculoviru
report
literatur
gronowski
et
al
histidin
tag
stimul
immun
system
respons
masek
et
al
therefor
also
amplifi
clone
sequenc
two
protein
molecular
weight
similar
protein
histidin
sequenc
confirm
protect
effect
observ
result
would
due
action
antivir
protein
l
obliqua
respons
immun
system
histag
sequenc
masek
et
al
veiga
et
al
l
obliqua
caterpillar
specimen
crosssect
middl
extrem
cut
rna
extract
remain
portion
trizol
invitrogen
accord
manufactur
instruct
rna
store
use
firststrand
cdna
synthes
use
oligo
dt
primer
fermenta
superscript
iii
revers
transcriptas
invitrogen
amplif
sequenc
interest
pcr
consist
pcr
master
mix
promega
ng
cdna
lm
specif
primer
carri
thermocycl
follow
reaction
condit
initi
cycl
min
cycl
min
temperatur
gradient
rang
min
min
final
extens
min
amplif
product
analyz
electrophoresi
agaros
gel
contain
ethidium
bromid
lgml
donor
vector
use
first
clone
step
clone
reaction
vector
amplifi
cdna
digest
bamhi
hindiii
restrict
enzym
overnight
incub
ligat
reaction
employ
transform
e
coli
bacteria
grown
plate
contain
lb
medium
ampicillin
lgml
twenti
coloni
select
growth
liquid
luriabertani
lb
contain
ampicillin
lgml
select
coloni
contain
recombin
donor
plasmid
cultur
analyz
pcr
use
primer
specif
cdna
antivir
protein
protein
agaros
gel
electrophoresi
perform
verifi
amplifi
product
confirm
insert
appropri
ligat
clone
vector
clone
screen
pcr
restrict
enzym
digest
also
subject
sequenc
analys
primer
seq
forward
seq
revers
cycl
sequenc
reaction
perform
use
bigdy
termin
cycl
sequenc
kit
code
appli
biosystem
capillari
electrophoresi
sequenc
analys
perform
abi
dna
analyz
appli
biosystem
use
cm
capillari
load
sequenc
analyz
sequenc
analysi
softwar
gener
construct
cdna
antivir
protein
protein
purifi
plasmid
dna
transform
e
coli
transposit
bacmid
identif
coloni
contain
recombin
bacmid
base
bluewhit
coloni
select
extract
bacmid
perform
accord
manufactur
protocol
bactobac
baculoviru
express
system
invitrogen
verifi
presenc
gene
interest
transposit
pcr
primer
use
obtain
amplicon
sequenc
use
primer
confirm
presenc
gene
interest
bacmid
transposit
transfect
insect
cell
recombin
bacmid
perform
accord
bactobac
baculoviru
express
system
manual
cell
log
phase
cellsml
greater
viabil
use
experi
use
ng
recombin
baculoviru
transfect
cell
morpholog
observ
daili
post
infect
sign
viral
infect
h
supernat
collect
consid
first
passag
recombin
baculoviru
confirm
nucleotid
sequenc
recombin
protein
sampl
cultur
infect
second
pass
collect
h
extract
dna
rna
pcr
rtpcr
carri
respect
previous
indic
dna
sampl
result
pcr
subject
nucleotid
sequenc
forward
revers
primer
use
amplif
cdna
supernat
crop
collect
daili
determin
cell
number
nutrient
titrat
baculoviru
recombin
protein
identif
data
shown
western
blot
antihi
antibodi
ge
healthcar
studi
cell
morpholog
photomicrograph
perform
step
cell
grown
plastic
tflask
multiwel
plate
use
medium
contain
g
l
dgalactos
g
l
lglutamin
supplement
fetal
bovin
serum
fb
viabl
cell
count
perform
neubauer
chamber
use
trypan
blue
exclus
method
order
determin
amount
viru
produc
cultur
infect
emc
viru
block
antivir
recombin
protein
ravlo
treat
treat
vv
ravlo
h
prior
cultur
infect
cell
infect
emc
viru
differ
dilut
rate
microwel
plate
contain
emcinfect
cell
incub
day
describ
griffith
thornton
titer
viru
produc
infect
cell
treat
treat
ravlo
determin
monitor
cytopath
effect
cpe
endpoint
dilut
assay
result
express
highest
dilut
viru
abl
induc
cpe
cell
protein
respons
antivir
effect
l
obliqua
hemolymph
isol
purifi
gel
filtrat
chromatographi
use
superdex
column
semipurifi
fraction
contain
antivir
activ
appli
onto
ionexchang
resourceq
column
previous
demonstr
group
antivir
protein
purifi
procedur
decreas
product
measl
viru
tcid
ml
time
product
polioviru
tcid
ml
time
differ
signific
p
mass
spectrometri
use
determin
ntermin
protein
ntermin
sequenc
analyz
previous
construct
l
obliqua
cdna
librari
veiga
et
al
rna
extract
cdna
gener
describ
section
sampl
analyz
agaros
gel
band
bp
observ
confirm
amplif
cdna
code
antivir
protein
fig
sequenc
cdna
code
protein
pb
pb
also
confirm
agaros
gel
electrophoresi
fig
amplifi
cdna
code
antivir
protein
clone
donor
plasmid
observ
agaros
gel
electrophoresi
fig
clone
cdna
expect
size
bp
antivir
protein
bp
bp
fig
e
coli
cell
transform
recombin
donor
plasmid
plasmidcontain
coloni
select
purifi
plasmid
subsequ
use
transform
e
coli
construct
recombin
bacmid
bacmid
contain
sequenc
protein
antivir
activ
protein
use
express
protein
cell
system
shown
bacteri
transform
recombin
plasmid
white
blue
coloni
observ
plate
white
coloni
indic
success
transposit
occur
blue
coloni
indic
bacmid
remain
unchang
coloni
recombin
bacmid
analyz
pcr
follow
agaros
gel
electrophoresi
baculoviru
transposit
confirm
appear
dna
band
antivir
protein
fig
protein
protein
data
shown
recombin
plasmid
select
e
coli
subsequ
use
transform
e
coli
construct
recombin
bacmid
bacmid
contain
sequenc
protein
antivir
activ
chosen
protein
use
express
protein
cell
system
three
passag
recombin
viru
perform
cell
cultur
far
moment
titer
baculoviru
obtain
differ
passag
well
antivir
activ
recombin
protein
produc
system
determin
elimin
possibl
observ
effect
due
characterist
construct
antivir
activ
use
approach
procedur
construct
recombin
bacmid
express
l
obliqua
protein
name
veiga
et
al
two
recombin
bacmid
well
empti
bacmid
use
treat
cell
infect
picornaviru
result
show
empti
bacmid
express
recombin
protein
effect
inhibit
replic
emc
viru
present
result
similar
control
infect
cell
untreat
cell
hand
infect
cultur
treat
recombin
antivir
reduct
log
viral
titer
comparison
control
therefor
purifi
antivir
protein
use
reduct
viru
produc
around
log
show
recombin
antivir
protein
remain
fulli
activ
tabl
current
test
effect
antivir
purifi
recombin
protein
envelop
virus
measl
rubella
herp
simplex
preliminari
data
shown
purifi
recombin
protein
abl
reduc
least
log
replic
rubella
viru
log
replic
herp
simplex
viru
data
shown
facilit
purif
histag
sequenc
includ
ctermin
region
protein
ravlo
protein
separ
sdspage
transfer
nitrocellulos
membran
sambrook
russel
transfer
membran
mark
antihistidin
antibodi
confirm
presenc
protein
result
shown
fig
seen
presenc
band
strong
label
antibodi
demonstr
express
antivir
protein
viral
diseas
affect
hundr
million
peopl
worldwid
everi
year
even
though
antivir
drug
clinic
trial
direct
toward
treatment
hiv
therefor
need
develop
antivir
agent
specif
emerg
newlyrecogn
human
pathogen
sar
coronaviru
influenza
virus
delcroix
riley
recent
variou
studi
report
antivir
properti
product
obtain
arthropod
popham
et
al
report
signific
reduct
titer
baculoviru
hzsnpv
due
action
antivir
protein
present
hemolymph
h
virescen
larva
chernysh
et
al
isol
two
peptid
alloferon
hemolymph
calliphora
vicina
control
viral
infect
ad
infect
olicard
et
al
observ
addit
hemolymph
crassostrea
giga
vero
cell
cultur
inhibit
extract
crustacean
tissu
also
shown
broad
spectrum
antivir
activ
envelop
nonenvelop
dna
rna
virus
probabl
multipl
inhibitor
contain
extract
pan
et
al
hultmark
et
al
report
antimicrobi
properti
protein
kda
isol
hyalophora
cecropia
caterpillar
alloferon
kda
protein
purifi
hemolymph
fli
c
vicina
effect
inhibit
reproduct
influenza
b
virus
trigger
intracellular
respons
ad
viru
infect
similar
interferon
vertebr
chernysh
et
al
antivir
peptid
da
isol
h
virescen
hemolymph
provid
protect
viru
infect
ourth
recent
group
purifi
antivir
protein
approxim
kda
hemolymph
l
obliqua
ad
cultur
h
infect
protein
abl
inhibit
replic
virus
test
respect
studi
present
studi
clone
express
recombin
antivir
protein
l
obliqua
caterpillar
name
ravlo
furthermor
result
confirm
recombin
protein
display
antivir
effect
observ
nativ
protein
present
hemolymph
matter
fact
recombin
protein
abl
inhibit
replic
picornaviru
also
observ
hemolymph
display
virucid
effect
hb
ravlo
whole
ravlo
purifi
rec
ccid
cell
cultur
infecti
dose
valu
repres
averag
three
experi
indic
valu
p
suggest
may
act
differ
stage
viru
replic
similar
alloferon
late
stage
viru
infect
demonstr
popham
et
al
peptid
extract
h
virescen
studi
antivir
activ
l
obliqua
hemolymph
human
virus
determin
vitro
protein
character
mass
spectrometri
protocol
use
amplif
cdna
protein
clone
shown
effici
obtain
bacmid
contain
sequenc
protein
antivir
activ
use
express
protein
cell
cultur
shown
ravlo
abl
block
replic
encephalomyocard
viru
nonenvelop
viru
indic
ravlo
kept
antivir
activ
nativ
protein
hemolymph
base
result
propos
protein
present
hemolymph
caterpillar
l
obliqua
display
antivir
activ
play
put
role
insect
immun
studi
activ
recombin
protein
envelop
viru
rubella
viru
herp
simplex
viru
measl
viru
perform
case
viru
replic
inhibit
log
rubella
viru
log
herp
simplex
viru
data
shown
product
protein
optim
uflag
insect
cell
also
determin
stabil
ravlo
well
defin
effect
dose
protein
